Deutsche Bank Ag\ Exelixis, Inc. Transaction History

Deutsche Bank Ag\

$248 Billion
Q4 2024

A detailed history of Deutsche Bank Ag\ transactions in Exelixis, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 46,289 shares of EXEL stock, worth $1.72 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

46,289

Previous 50,859 8.99%

Holding current value

$1.72 Million

Previous $1.32 Million 16.83%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$25.39 - $36.46 $116,032 - $166,622	-4,570 Reduced 8.99%	46,289 $1.54 Million
Q3 2024 Nov 13, 2024	SELL	$21.96 - $27.6 $4.69 Million - $5.89 Million	-213,463 Reduced 80.76%	50,859 $1.32 Million
Q2 2024 Aug 14, 2024	SELL	$20.34 - $23.73 $175,473 - $204,718	-8,627 Reduced 3.16%	264,322 $5.94 Million
Q1 2024 May 15, 2024	BUY	$20.17 - $23.93 $414,715 - $492,024	20,561 Added 8.15%	272,949 $6.48 Million
Q4 2023 Feb 14, 2024	SELL	$19.25 - $24.13 $386,058 - $483,927	-20,055 Reduced 7.36%	252,388 $6.05 Million
Q3 2023 Nov 09, 2023	SELL	$19.04 - $22.74 $2.76 Million - $3.29 Million	-144,820 Reduced 34.71%	272,443 $5.95 Million
Q2 2023 Aug 14, 2023	BUY	$18.17 - $20.48 $2.1 Million - $2.37 Million	115,543 Added 38.29%	417,263 $7.97 Million
Q1 2023 May 15, 2023	SELL	$16.3 - $19.41 $36.6 Million - $43.6 Million	-2,248,340 Reduced 88.17%	301,720 $5.86 Million
Q4 2022 Feb 13, 2023	BUY	$14.96 - $17.39 $1.36 Million - $1.58 Million	91,086 Added 3.7%	2,550,060 $40.9 Million
Q3 2022 Nov 14, 2022	SELL	$15.68 - $22.27 $16.6 Million - $23.6 Million	-1,059,748 Reduced 30.12%	2,458,974 $38.6 Million
Q2 2022 Aug 11, 2022	BUY	$17.44 - $23.16 $50 Million - $66.4 Million	2,866,622 Added 439.6%	3,518,722 $73.3 Million
Q1 2022 May 13, 2022	SELL	$17.03 - $22.67 $1.73 Million - $2.3 Million	-101,462 Reduced 13.46%	652,100 $14.8 Million
Q4 2021 Feb 11, 2022	SELL	$15.84 - $21.88 $10.9 Million - $15 Million	-686,651 Reduced 47.68%	753,562 $13.8 Million
Q3 2021 Nov 04, 2021	BUY	$16.3 - $21.14 $902,384 - $1.17 Million	55,361 Added 4.0%	1,440,213 $30.4 Million
Q2 2021 Aug 11, 2021	BUY	$17.95 - $25.56 $957,919 - $1.36 Million	53,366 Added 4.01%	1,384,852 $25.2 Million
Q1 2021 May 13, 2021	BUY	$20.53 - $25.22 $23.8 Million - $29.2 Million	1,157,844 Added 666.8%	1,331,486 $30.1 Million
Q4 2020 Feb 16, 2021	SELL	$18.39 - $24.8 $340,380 - $459,023	-18,509 Reduced 9.63%	173,642 $3.49 Million
Q3 2020 Nov 12, 2020	BUY	$20.67 - $26.94 $711,730 - $927,625	34,433 Added 21.83%	192,151 $4.7 Million
Q2 2020 Aug 13, 2020	SELL	$16.46 - $27.42 $1.89 Million - $3.16 Million	-115,070 Reduced 42.18%	157,718 $3.74 Million
Q1 2020 May 14, 2020	BUY	$14.46 - $21.8 $2.49 Million - $3.75 Million	171,906 Added 170.4%	272,788 $4.7 Million
Q4 2019 Feb 14, 2020	SELL	$15.15 - $18.89 $135,547 - $169,008	-8,947 Reduced 8.15%	100,882 $1.77 Million
Q3 2019 Nov 14, 2019	SELL	$17.68 - $22.65 $13.3 Million - $17 Million	-752,567 Reduced 87.26%	109,829 $1.94 Million
Q2 2019 Aug 14, 2019	SELL	$18.93 - $24.75 $16 Million - $20.9 Million	-843,206 Reduced 49.44%	862,396 $18.4 Million
Q1 2019 May 15, 2019	BUY	$19.6 - $24.76 $5.49 Million - $6.94 Million	280,185 Added 19.66%	1,705,602 $40.6 Million
Q4 2018 Feb 14, 2019	SELL	$13.65 - $21.8 $13.1 Million - $20.9 Million	-958,010 Reduced 40.19%	1,425,417 $28 Million
Q3 2018 Dec 21, 2021	BUY	$15.87 - $22.4 $15.6 Million - $22 Million	981,137 Added 69.97%	2,383,427 $42.2 Million
Q3 2018 Nov 14, 2018	SELL	$15.87 - $22.4 $45.3 Million - $64 Million	-2,855,389 Reduced 67.06%	1,402,290 $24.8 Million
Q2 2018 Apr 21, 2020	BUY	$18.56 - $22.45 $19.1 Million - $23 Million	1,026,469 Added 31.77%	4,257,679 $91.6 Million
Q2 2018 Aug 14, 2018	BUY	$18.56 - $22.45 $31.2 Million - $37.8 Million	1,681,766 Added 108.54%	3,231,210 $69.5 Million
Q1 2018 Oct 18, 2019	BUY	$22.15 - $31.89 $4.8 Million - $6.91 Million	216,570 Added 16.25%	1,549,444 $34.3 Million
Q1 2018 May 15, 2018	BUY	$22.15 - $31.89 $12.7 Million - $18.3 Million	573,893 Added 75.61%	1,332,874 $29.5 Million
Q4 2017 Feb 14, 2018	BUY	$24.23 - $30.93 $1.23 Million - $1.57 Million	50,877 Added 7.18%	758,981 $23.1 Million
Q3 2017 Nov 14, 2017	BUY	$23.35 - $29.24 $16.5 Million - $20.7 Million	708,104	708,104 $17.2 Million

Others Institutions Holding EXEL

# of Institutions

566

Shares Held

251M

Call Options Held

1.45M

Put Options Held

1.13M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $11.9B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account